Subspecialty	Gastroenterology
Gender	Male
Education and Training	Internship, Internal Medicine, Universitat Hamburg
	Residency, Internal Medicine, NYU Downtown Hospital
	Fellowship, Infectious Diseases, Veterans Administration NY Harbor Health System

Education and Training	Internship, Internal Medicine, Universitat Hamburg
	Residency, Internal Medicine, NYU Downtown Hospital
	Fellowship, Infectious Diseases, Veterans Administration NY Harbor Health System

Subspecialty	Gastroenterology

Research Interest
Epidemiology, natural history, and therapy of chronic hepatitis C, with and without HIV coinfection.  Hepatocellular carcinoma in HIV-infected patients.

Brau N, Fox RK, Xiao P, Marks K, Naqvi Z, Taylor LE. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A U.S.-Canadian multicenter study. J Hepatol 2007 Oct; 47(4): 527-537.

Dore GJ, Torriani FJ, Rodriguez-Torres M, Brau N, Sulkowski M, Lamoglia RS. Baseline factors prognostic of sustained virological response in patients with HIV-hepatitis C virus co-infection. AIDS 2007 Jul 31; 21(12): 1555-1559.

Soriano V, Puoti M, Sulkowski M, Cargnel A, Benhamou Y, Peters M, Mauss S, Brau N, Hatzakis A, Pol S, Rockstroh J. Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel. AIDS 2007 May 31; 21(9): 1073-1089.

Alvarez D, Dieterich DT, Brau N, Moorehead L, Ball L, Sulkowski MS. Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons. J Viral Hepat 2006 Oct; 13(10): 683-689.

Bini EJ, Currie SL, Shen H, Brau N, Schmidt W, Anand BS, Chung R, Sulkowski MS. National Multicenter Study of HIV Testing and HIV Seropositivity in Patients With Chronic Hepatitis C Virus Infection. J Clin Gastroenterol 2006 Sep; 40(8): 732-739.

Brau N, Bini EJ, Currie S, Shen H, Schmidt WN, King PD, . Black Patients with Chronic Hepatitis C Have a Lower Sustained Viral Response Rate than Non-blacks with Genotype 1, but the Same with Genotypes 2/3, and This Is Not Explained by More Frequent Dose Reductions of Interferon and Ribavirin. J Viral Hepat 2006 Apr 13; 13(4): 242-249.

Brau N, Salvatore M, Rios-Bedoya CF, Fernandez-Carbia A, Rodriguez-Orengo JF, Rodriguez-Torres M. Slower Fibrosis Progression in HIV/HCV-Coinfected Patients with Successful HIV Suppression Using Antiretroviral Therapy. J Hepatol 2006 Jan; 44(1): 47-55.

Jacobson IM, Gonzalez SA, Lebovics E, Min AD, Bodenheimer HC, Esposito SP, Brown RS, Brau N, Klion FM, Tobias H, Bini EJ. A Randomized Trial of Pegylated Interferon Alfa-2b plus Ribavirin in the Retreatment of Patients with Chronic Hepatitis C Unresponsive to Prior Therapy. Am J Gastroenterol 2005 Nov; 100(11): 2453-2462.

Bini EJ, Brau N, Currie S, Shen H, Anand BS, Hu KQ. Prospective Multicenter Study of Eligibility for Antiviral Therapy Among 4,084 U.S. Veterans With Chronic Hepatitis C Virus Infection. Am J Gastroenterol 2005 Aug; 100: 1772-1779.

Brau N, . Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients in the Era of Pegylated Interferon and Ribavirin. Semin Liver Dis 2005 Feb; 25(1): 33-51.

Brau N, Rodriguez-Torres M, Prokupek D, Bonacini M, Giffen CA, Smith JJ, Frost KR, Kostman JR. Treatment of chronic hepatitis C in HIV/HCV-coinfected patients with interferon alfa-2b plus full-course versus 16-week delayed ribavirin. Hepatology 2004 Apr; 39(4): 989-998.

Brau N, Bini EJ, Shahidi A, Aytaman A, Xiao P, Stancic S, Eng R, Brown S, Paronetto F. Hepatitis C And Coinfection With HIV-1 in The New York City Metropolitan Area: A Random Survey Among U.S. Veterans. Am J Gastroenterol 2002 Aug; 97(8): 2071-2078.

Brau N, Leaf HL, Wieczorek RL, Margolis DM. Severe hepatitis in three AIDS patients treated with indinavir. Lancet 1997; 349: 924-925.